Progestin intrauterine devices versus copper intrauterine devices for emergency contraception.

Ramanadhan, Shaalini; Goldstuck, Norman; Henderson, Jillian T; Che, Yan; Cleland, Kelly; Dodge, Laura E; Edelman, Alison

Ramanadhan, Shaalini; Goldstuck, Norman; Henderson, Jillian T; Che, Yan; Cleland, Kelly; Dodge, Laura E; Edelman, Alison.

Afiliação

Ramanadhan S; Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA.
Goldstuck N; Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Stellenbosch, Francie van Zyl Dr, Tygerberg Hospital, Bellville, Cape Town 7505, South Africa.
Henderson JT; Fertility Regulation Group, Oregon Health Sciences University, Portland, OR, USA.
Che Y; NHC Key Lab of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), Fudan University, Shanghai, China.
Cleland K; American Society for Emergency Contraception, Princeton, NJ, USA.
Dodge LE; Beth Israel Deaconess Medical Center, Boston, MA, USA.
Edelman A; Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA.

Cochrane Database Syst Rev ; 2: CD013744, 2023 02 27.

Article em En | MEDLINE | ID: mdl-36847591

Assuntos

Anticoncepção Pós-Coito; Dispositivos Intrauterinos de Cobre; Dispositivos Intrauterinos; Feminino; Humanos; Gravidez; Cobre; Dispositivos Intrauterinos de Cobre/efeitos adversos; Progestinas; Ensaios Clínicos Controlados Aleatórios como Assunto; Esteroides

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticoncepção Pós-Coito / Dispositivos Intrauterinos / Dispositivos Intrauterinos de Cobre Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Female / Humans / Pregnancy Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google